# FDA 483 - Cdymax (India) Pharma Private Limited - April 21, 2025

Source: https://www.keypedia.com/records/483/cdymax-india-pharma-private-limited/4f789568-92b1-481f-94fa-3cf55a8993d3

> FDA 483 for Cdymax (India) Pharma Private Limited on April 21, 2025. Product: N/A. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Cdymax (India) Pharma Private Limited
- Inspection Date: 2025-04-21

## Related Documents

- [483 - 2019-05-17](https://www.keypedia.com/records/483/cdymax-india-pharma-private-limited/6bebb67d-1710-4855-b96c-9c78b3cbb505)
- [483 - 2025-04-25](https://www.keypedia.com/records/483/cdymax-india-pharma-private-limited/6a4e0715-7b86-4b4f-9b03-429b9b408bdd)
- [483 - 2025-04-25](https://www.keypedia.com/records/483/cdymax-india-pharma-private-limited/ad76f291-4112-477b-8826-ea0caae6e696)
- [483 - 2025-04-21](https://www.keypedia.com/records/483/cdymax-india-pharma-private-limited/0d670442-e628-444c-b143-868c0109e677)
- [WARNING_LETTER - 2025-04-25](https://www.keypedia.com/records/warning_letter/cdymax-india-pharma-private-limited/5483d583-5418-4d4b-8801-ace48e9e8d53)

## Related Officers

- [Arsen Karapetyan](https://www.keypedia.com/people/arsen-karapetyan/4000d909-277b-4533-992f-4e3627c8ce40)

Company: https://www.keypedia.com/companies/cdymax-india-pharma-private-limited/51bc8d84-9900-43c0-8e1c-9d2bd08b0ac4
